Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chlamydia trachomatis infections: progress and problems.

W E Stamm1

  • 1Division of Allergy and Infectious Diseases, University of Washington, School of Medicine, Seattle 98195, USA.

The Journal of Infectious Diseases
|March 19, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Horizontal transfer of tetracycline resistance among Chlamydia spp. in vitro.

Antimicrobial agents and chemotherapy·2009
Same author

Prospective cohort study of microbial and inflammatory events immediately preceding Escherichia coli recurrent urinary tract infection in women.

The Journal of infectious diseases·2009
Same author

Chlamydia trachomatis laboratory strains versus recent clinical isolates: implications for routine microbicide testing.

Antimicrobial agents and chemotherapy·2009
Same author

Urinary tract infections in women with type 1 diabetes mellitus: survey of female participants in the epidemiology of diabetes interventions and complications study cohort.

The Journal of urology·2009
Same author

Detection of Mycoplasma genitalium in women with laparoscopically diagnosed acute salpingitis.

Sexually transmitted infections·2005
Same author

Susceptibility of Chlamydia trachomatis to excipients commonly used in topical microbicide formulations.

Antimicrobial agents and chemotherapy·2004

Community screening for Chlamydia trachomatis (CT) using nucleic acid amplification tests (NAATs) effectively identifies asymptomatic infections. This approach, combined with azithromycin treatment, reduces CT prevalence and pelvic inflammatory disease incidence.

Area of Science:

  • Public Health
  • Infectious Diseases
  • Microbiology

Background:

  • Chlamydia trachomatis (CT) is the most common bacterial sexually transmitted infection (STI) in the United States.
  • A significant percentage of CT infections are asymptomatic in both men and women.
  • Complications like pelvic inflammatory disease (PID) and upper genital tract scarring can result from CT infections.

Purpose of the Study:

  • To evaluate the effectiveness of community-based screening programs for asymptomatic Chlamydia trachomatis infections.
  • To assess the impact of screening and directly observed single-dose azithromycin therapy on CT prevalence and sequelae.
  • To explore the immunopathologic mechanisms underlying CT-related sequelae, including the role of heat-shock proteins and genetic predisposition.

Main Methods:

Related Experiment Videos

  • Utilized nucleic acid amplification-based diagnostic tests (NAATs) on first-void urine samples for community-based screening.
  • Implemented directly observed single-dose therapy with azithromycin for identified infections.
  • Analyzed data on chlamydial infection prevalence and incidence of pelvic inflammatory disease in screened populations.

Main Results:

  • Community screening programs significantly reduced the overall prevalence of chlamydial infection within the tested population.
  • Screened women demonstrated a reduced incidence of subsequent pelvic inflammatory disease.
  • The study highlights the role of chlamydial 60 kDa heat-shock protein and host genetic factors in infection sequelae.

Conclusions:

  • Community-based screening using NAATs is an effective strategy for controlling Chlamydia trachomatis infections.
  • Directly observed azithromycin therapy is a viable treatment option within screening programs.
  • Further research into the immunologic events causing upper genital tract scarring is crucial for developing targeted interventions and vaccines.